To The Moon

$NVIDIA(NVDA)$ $Broadcom(AVGO)$  $Oracle(ORCL)$  📊🚀🌍 S&P 500 Earnings Just Crushed Expectations. Two Giants Still Hold the Final AI Catalyst 🚀🧠📈 I’m looking at Q1 earnings season and the signal is becoming increasingly difficult for the market to ignore. Corporate America did not simply clear expectations. It materially outperformed them. With $NVDA and $WMT now reported, only two of the top 50 $SPX components by market cap remain this quarter: 💽 $AVGO reporting 03Jun26 ☁️ $ORCL reporting 16Jun26 That effectively puts a bow on Q1 earnings season. And the scoreboard looks materially stronger than many expected coming into April when markets

$Salesforce.com(CRM)$ $Snowflake(SNOW)$  $MongoDB Inc.(MDB)$  📊🌍🚀 Wall Street this week: macro, geopolitics and software earnings in focus 🚀🌍📊 I’m heading into this shortened trading week with three interlocking forces shaping price action: geopolitical tension in the Middle East, critical U.S. macro data and a concentrated software and technology earnings calendar. With U.S. markets closed Monday for Memorial Day, the trading week compresses into four sessions, but the amount of information the market needs to absorb feels anything but light. The next few days could influence sector leadership, macro expectations and positioning into June. 📅 Ke

$IONQ Inc.(IONQ)$ $D-Wave Quantum Inc.(QBTS)$  $Rigetti Computing(RGTI)$  ⚛️📈🚀 Quantum Stocks Are No Longer Trading On Fundamentals. They’re Trading On Institutional Legitimacy. 🚀📈⚛️ The market is no longer waiting for quantum profits. It’s front-running quantum credibility. That shift is rapidly becoming one of the most important speculative dynamics in global tech markets, and it explains why names like $IONQ, $QBTS, and $RGTI keep experiencing violent repricing every time a powerful institution validates the sector. I’m watching quantum equities behave less like traditional software companies and more like early-stage AI infrastructure play

$Wal-Mart(WMT)$ $Costco(COST)$  $Target(TGT)$  🛒📉🏦 Walmart Just Delivered A Quarter The Market Didn’t Want To Reward 🏦📉🛒 $WMT losses accelerated to around -7%, marking its worst single-day decline since Nov 2023 and wiping roughly 55 points off the DJIA. What makes the reaction fascinating is that operationally, Walmart actually delivered another strong quarter. Revenue beat. Traffic grew. eCommerce accelerated. Advertising surged. International remained strong. But Wall Street was focused somewhere else entirely: free cash flow deterioration, rising capex intensity, slowing implied physical-store trends, and softer earnings guidance. That shift

$Qualcomm(QCOM)$ $Oracle(ORCL)$  $Coinbase Global, Inc.(COIN)$  🔥📈🚀 The Smart Money Rotation Since April Has Been Impossible To Ignore 🚀📈🔥 Since early April, one of the most aggressive speculative rotations of 2026 has been unfolding right in front of us. Not in defensives. Not in safety trades. Not in low-beta hiding spots. Capital has been flooding directly into AI infrastructure, software, semiconductors, energy, cloud ecosystems, cyclicals, and momentum growth. What makes this move fascinating is not simply the magnitude of the rallies. It’s the options positioning underneath them. $QCOM surging +60.6% while simultaneously maintaining one

$SanDisk Corp.(SNDK)$ $Micron Technology(MU)$  $Microsoft(MSFT)$  💾🚀📈 The AI Memory Bottleneck Trade Is Turning Parabolic 📈🚀💾 I’m watching one of the most aggressive sentiment repricings in the semiconductor complex unfold in real time as AI infrastructure demand collides with a structural memory shortage that still shows little sign of easing. After an astonishing 3,300% 12-month rally, $SNDK is no longer trading like a traditional storage company. I’m seeing the market increasingly price it as a critical AI infrastructure bottleneck asset, sitting directly in the path of hyperscaler capex expansion, enterprise AI deployment and accelerating hi

$ServiceNow(NOW)$ $Microsoft(MSFT)$  $NVIDIA(NVDA)$  💻🚀📈 ServiceNow $NOW Is Starting To Look Like A Major Enterprise AI Reacceleration Trade 📈🚀💻 I’m watching NOW extremely closely because today’s move is beginning to look far more important than a standard analyst upgrade reaction. $NOW surged more than +8% after Bank of America reinstated coverage with a Buy rating and a $130 price target, helping trigger one of the most aggressive options positioning shifts seen recently in large-cap enterprise software. What immediately caught my attention was the options flow. $NOW represented roughly 7% of all traded options volume today outside of the Mag

$Ondas Holdings Inc.(ONDS)$ $Palantir Technologies Inc.(PLTR)$  $AeroVironment(AVAV)$  🛰️⚔️📈 $ONDS Q1 2026: Defense AI Ambitions Go Hypergrowth While Cash Burn Explodes 📈⚔️🛰️ Ondas just delivered one of the most aggressive small-cap defense growth quarters of 2026. Revenue exploded +1065% YoY to $50.1M, backlog surged to a staggering $457M, and management raised FY26 guidance again as the company races to build what increasingly resembles a vertically integrated autonomous warfare and ISR ecosystem. But beneath the surface, this quarter was also a masterclass in financial engineering, acquisition-fuelled scaling, and operational complexity. Th

$Alibaba(BABA)$ $Tencent Holding Ltd.(TCEHY)$  $JD.com(JD)$  🇨🇳🤖📉 $BABA Just Reported One Of Its Most Important AI Transition Quarters In Years, And The Market Hated It 📉🤖🇨🇳 Alibaba is now attempting something incredibly difficult simultaneously: • Funding an AI infrastructure supercycle • Defending e-commerce market share • Rebuilding investor confidence amid collapsing margins The result was a quarter where strategic positioning strengthened dramatically, while earnings quality deteriorated almost everywhere else. $BABA slipped in electronic trading after missing revenue expectations despite a profit beat headline. Investors immediately focus

$Hims & Hers Health Inc.(HIMS)$ $Novo-Nordisk A/S(NVO)$  $Eli Lilly(LLY)$  💊📉🔥 $HIMS Just Lost Its Highest-Margin Growth Engine 🔥📉💊 $HIMS is getting punished after its GLP-1 cash cow hit a wall. The company’s pivot away from compounded Wegovy copycats toward branded $NVO and $LLY therapies just detonated profitability, crushed margins, and exposed how dependent the growth story had become on one exceptionally lucrative category. The market reaction says it all. 🔴 EPS: -$0.40 vs Est. $0.03 🔴 Revenue: $608.1M vs Est. $616.9M 🔴 First quarterly loss in 3 years 🔴 Gross Margin: 65% vs 73% YoY 🔴 U.S. Revenue: -8% YoY 🔴 Stock slammed double digits p